<DOC>
	<DOCNO>NCT00223678</DOCNO>
	<brief_summary>A study determine effect renal function renal transplant patient biopsy proven CAN nephropathy switch CI triple drug regimen Rapamycin base triple drug regimen maintain CI protocol</brief_summary>
	<brief_title>Mycophenolate Mofetil Rapamycin Secondary Intervention v . Continuation Calcineurin Inhibitors Patients Risk Chronic Renal Allograft Failure</brief_title>
	<detailed_description />
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>1 . Patient recipient cadaveric live donor renal transplant . 2 . Patient &gt; 12 year age time transplant . 3 . Patient least 3 month posttransplant . 4 . Patient calcineurin inhibitor base immunosuppression since transplant . 5 . Patient one follow risk factor chronic renal allograft failure : I. Serum creatinine &gt; 2.0 mg/dL 3 month later posttransplant male patient . II . Serum creatinine &gt; 1.7 mg/dL 3 month later posttransplant female patient . III . Serum &gt; 30 % increase post discharge nadir . 6 . Patients renal biopsy show chronic allograft nephropathy . 7 . Patient legal guardian sign dated IRB approve informed consent document willing able follow study procedure . 8 . If female child bear potential , patient negative pregnancy test agree practice effective birth control receive mycophenolate mofetil ( MMF ) , Rapamycin immunosuppressant . 1 . Patient recipient solid organ transplant kidney . 2 . Patient dialysis dependent . 3 . Patient recurrence primary renal disease , de novo renal disease . 4 . Patient estimate creatinine clearance &lt; 25ml/min calculate use Crockcroft/Gault formula . 5 . Patient change maintenance immunosuppressant therapy ( e.g. , azathioprine MMF ) within three month randomization . 6 . Baseline biopsy show acute rejection Banff Grade &gt; IIB . 7 . Patient require antilymphocyte therapy treat rejection find baseline biopsy . 8 . Patient receive investigational immunosuppressant within three month . 9 . Patient pregnant lactating . 10 . Patient know carrier HIV viruses . 11 . Patient known hypersensitivity Rapamycin , excipients drug .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
</DOC>